date,title,source
Oct-18-18,"Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the North American Cystic Fibrosis Conference (NACFC)",GlobeNewswire
Nov-08-18,Eloxx Pharmaceuticals Reports Third Quarter 2018 Financial and Operating Results and Provides Business Update,GlobeNewswire
